What are the safety concerns with long-term 5-Amino-1MQ use
Signs include: Hives or widespread rash beyond the injection site Swelling of face, lips, tongue, or throat Difficulty breathing or wheezing Rapid heartbeat Feeling faint or losing consciousness These symptoms require immediate medical attention
There is an increased interest and potential in this exciting area of research, and the future looks bright for nasal inhalation delivery for CNS and brain therapeutic applications, hand in hand with the development of peptides as drug candidates, to be delivered intranasally
Are purity standards mentioned
When to increase dose Consider increasing if: Minimal response after 4-6 weeks at current dose No side effects at current dose Current dose below the higher end of recommended range Goals not being met with conservative approach Increase gradually, typically by 25-50% at a time
The two are mechanistically separate compounds with independent literatures, and each is studied on its own terms rather than as a validated combination